Filing Flows › Globus Medical (GMED) › R&D spending
Globus Medical (GMED) R&D spending by quarter
Globus Medical's R&D spending was $34.5M in Q3 2026 (third quarter 2026), -5% from Q2 2026. Over the last 7 quarters it ranged from $33.1M (Q1 2025) to $40.0M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $34.5M | -5% | -9% |
| Q2 2026 | $36.3M | -0.5% | -9% |
| Q1 2026 | $36.5M | +1% | +10% |
| Q4 2025 | $36.2M | -5% | — |
| Q3 2025 | $38.1M | -5% | — |
| Q2 2025 | $40.0M | +21% | — |
| Q1 2025 | $33.1M | — | — |
Q3 2026 at a glance
Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart follows the revenue to costs, profit and cash.
Questions
What is Globus Medical's R&D spending?
Globus Medical's R&D spending was $34.5M in Q3 2026 (third quarter 2026), -5% from Q2 2026.
How has Globus Medical's R&D spending changed?
Over the last 7 quarters it ranged from $33.1M (Q1 2025) to $40.0M (Q2 2025).